Efficacy and safety analysis of the German expanded access program of osimertinib in patients with advanced, T790M-positive non-small cell lung cancer

Stratmann, Jan A.; Michels, Sebastian; Hornetz, Sofia; Christoph, Daniel C.; Sackmann, Sandra; Spengler, Werner; Bischoff, Helge; Schaefer, Monica; Alt, Juergen; Mueller, Annette; Laack, Eckart; Kimmich, Martin; Griesinger, Frank; Sebastian, Martin

dc.contributor.author	Spengler, Werner
dc.date.accessioned	2019-07-09T08:15:21Z
dc.date.available	2019-07-09T08:15:21Z
dc.date.issued	2018
dc.identifier.issn	1432-1335
dc.identifier.uri	http://hdl.handle.net/10900/90144
dc.language.iso	en	de_DE
dc.publisher	Springer	de_DE
dc.relation.uri	http://dx.doi.org/10.1007/s00432-018-2754-x	de_DE
dc.subject.ddc	610	de_DE
dc.title	Efficacy and safety analysis of the German expanded access program of osimertinib in patients with advanced, T790M-positive non-small cell lung cancer	de_DE
dc.type	Article	de_DE
utue.quellen.id	20190321153956_00320
utue.publikation.seiten	2457-2463	de_DE
utue.personen.roh	Stratmann, Jan A.
utue.personen.roh	Michels, Sebastian
utue.personen.roh	Hornetz, Sofia
utue.personen.roh	Christoph, Daniel C.
utue.personen.roh	Sackmann, Sandra
utue.personen.roh	Spengler, Werner
utue.personen.roh	Bischoff, Helge
utue.personen.roh	Schaefer, Monica
utue.personen.roh	Alt, Juergen
utue.personen.roh	Mueller, Annette
utue.personen.roh	Laack, Eckart
utue.personen.roh	Kimmich, Martin
utue.personen.roh	Griesinger, Frank
utue.personen.roh	Sebastian, Martin
dcterms.isPartOf.ZSTitelID	Journal of Cancer Research and Clinical Oncology	de_DE
dcterms.isPartOf.ZS-Issue	12	de_DE
dcterms.isPartOf.ZS-Volume	144	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE